<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/845F7CA5-F786-40DF-B429-C727CA83C9CF"><gtr:id>845F7CA5-F786-40DF-B429-C727CA83C9CF</gtr:id><gtr:name>University of Bamako</gtr:name><gtr:address><gtr:line1>University of Bamako</gtr:line1><gtr:line3>Darsalam</gtr:line3><gtr:postCode>BP276</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/52AF26DF-D9A2-4A76-881B-2C421B622C30"><gtr:id>52AF26DF-D9A2-4A76-881B-2C421B622C30</gtr:id><gtr:name>Heidelberg University Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C"><gtr:id>B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C</gtr:id><gtr:name>Pasteur Institute Dakar</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89194876-5CDA-41E5-8C0F-30A57B260DA2"><gtr:id>89194876-5CDA-41E5-8C0F-30A57B260DA2</gtr:id><gtr:name>Kintampo Health Research Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Tropical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/845F7CA5-F786-40DF-B429-C727CA83C9CF"><gtr:id>845F7CA5-F786-40DF-B429-C727CA83C9CF</gtr:id><gtr:name>University of Bamako</gtr:name><gtr:address><gtr:line1>University of Bamako</gtr:line1><gtr:line3>Darsalam</gtr:line3><gtr:postCode>BP276</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/52AF26DF-D9A2-4A76-881B-2C421B622C30"><gtr:id>52AF26DF-D9A2-4A76-881B-2C421B622C30</gtr:id><gtr:name>Heidelberg University Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C"><gtr:id>B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C</gtr:id><gtr:name>Pasteur Institute Dakar</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89194876-5CDA-41E5-8C0F-30A57B260DA2"><gtr:id>89194876-5CDA-41E5-8C0F-30A57B260DA2</gtr:id><gtr:name>Kintampo Health Research Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/32425D7C-A28A-46AB-8A8A-8B2BCA9B3583"><gtr:id>32425D7C-A28A-46AB-8A8A-8B2BCA9B3583</gtr:id><gtr:firstName>Jean</gtr:firstName><gtr:surname>Langhorne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B2F3B3ED-8B79-4562-89E6-7C8324D2F35B"><gtr:id>B2F3B3ED-8B79-4562-89E6-7C8324D2F35B</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Newbold</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/60FDE62B-2BDA-4E41-A0C3-9400A1891171"><gtr:id>60FDE62B-2BDA-4E41-A0C3-9400A1891171</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Marsh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BA4590AE-07B8-4B54-9DB9-836F8F6853CF"><gtr:id>BA4590AE-07B8-4B54-9DB9-836F8F6853CF</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Bejon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A7B65AA1-1261-401D-925E-C5775FDC8136"><gtr:id>A7B65AA1-1261-401D-925E-C5775FDC8136</gtr:id><gtr:firstName>Francis</gtr:firstName><gtr:otherNames>Maina</gtr:otherNames><gtr:surname>Ndungu</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DA3FC704-050E-4D0E-BED2-18752F070999"><gtr:id>DA3FC704-050E-4D0E-BED2-18752F070999</gtr:id><gtr:firstName>Mario</gtr:firstName><gtr:surname>Recker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/63BE3B61-445C-44F9-8B21-C3CB79544F9B"><gtr:id>63BE3B61-445C-44F9-8B21-C3CB79544F9B</gtr:id><gtr:firstName>Greg</gtr:firstName><gtr:surname>Elgar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FAB432B8-1996-4AD3-B8A8-CF614AB2DB16"><gtr:id>FAB432B8-1996-4AD3-B8A8-CF614AB2DB16</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:surname>Berriman</gtr:surname><gtr:orcidId>0000-0002-9581-0377</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9DBA563-B32D-4594-8A97-22E68F01D76C"><gtr:id>C9DBA563-B32D-4594-8A97-22E68F01D76C</gtr:id><gtr:firstName>Etienne</gtr:firstName><gtr:otherNames>Pierre</gtr:otherNames><gtr:surname>de Villiers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM003906%2F1"><gtr:id>F7023160-B778-4141-9314-D676B3F7EC01</gtr:id><gtr:title>A systems biology approach to understand immunity and pathogenesis of malaria in children</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M003906/1</gtr:grantReference><gtr:abstractText>Malaria is a major health problem, with approximately half of the world's population at risk. Most malaria cases and deaths occur in sub-Saharan Africa and are caused by the species &amp;quot;Plasmodium falciparum&amp;quot;, with an annual mortality rate of up to 700,000, mostly among children.. Despite many years of work and investment, we still do not have a highly effective vaccine. One reason for this is that we have an incomplete understanding of the interaction between malaria parasites and immunity. Immune responses to Plasmodium are complex, and protective immunity in malaria endemic areas develops only after several years of exposure. We know from our long-term studies of longitudinal cohorts that the outcome of malaria infection in children is extremely variable such that some children have two or three clinical episodes while others have very frequent clinical episodes or severe episodes without apparently becoming immune. Malaria can have a profound suppressive impact on immune responses. Our hypothesis is that these children with frequent and symptomatic malaria infections are caught in a causal &amp;quot;loop&amp;quot; (or &amp;quot;vicious cycle&amp;quot;) whereby malaria episodes lead to impaired immunity to malaria, which in turn leads to further episodes of malaria. 

In our first phase of analysis, we will investigate immune responses in a cohort of children developing immunity to P.falciparum malaria, for whom we have detailed life histories of malaria exposure. We will compare those immune responses of children with a history of repeated and clinical malaria episodes with those of children with a normal number of clinical malaria episodes (matching age, location and malaria exposure). We will also examine responses in a third group of children who live nearby, but are not exposed to malaria. This first phase of analysis will establish the analytical methodology, determine patterns of responses, and generate models and hypotheses that can be tested in the second phase (see below). We will combine transcriptomic, flow-cytometric, cytokine analyses, and malaria-specific B cell/antibody responses to compare as comprehensively as possible the features of the host response in the two groups. 

A single &amp;quot;snap shot&amp;quot; of immune responses may represent only the endpoint of immune processes and may not reflect those that are causally related to differences in malaria outcome. Therefore, in a second phase of testing, we will collect and store samples from the whole cohort prior to surveillance for clinical malaria episodes. Samples will be stored, and then tested and analysed when parallel groups to those describe for the first phase above can be identified (i.e. multiple episodes vs normal episodes). These samples will be analysed by the laboratory and analytical teams blinded to epidemiological data, and the association between the signatures identified in the first phase and malaria episodes in prospect will be examined. We will undertake a further cross-sectional assessment of the children in this cohort in the second year, in order to assess the stability of these markers over time.

Our studies will identify immune response patterns that can be used as predictive markers of the child's ability to develop immunity to clinical malaria, and will be of great value in informing rational vaccine design, and monitoring vaccine efficacy and therapeutics. We will establish a set of robust analytical and modeling tools, which can be used in further studies, which will combine genetic variation in parasite and host, and which will inform mechanistic studies in animal models. Our unique dataset will be available for other researchers, and the expertise acquired will help establish a systems immunology expertise in the UK.</gtr:abstractText><gtr:technicalSummary>We will examine immune response profiles of children developing immunity to Plasmodium falciparum malaria, in order to define a response pattern that distinguishes children who have suffered very frequent clinical malaria episodes from those who have an average number of clinical. We will then sample a cohort prior to surveillance, store the samples, and then test once clinical data are available to examine whether these profiles can prospectively predict multiple clinical episodes and failure to acquire immunity. 
Using RNA sequencing we will determine the transcriptome profile of the immune response. This will be combined with flow cytometric analyses on leukocytes in whole blood, and measurements of cytokines, chemokines and P. falciparum specific B cell/antibody responses. 
At each analytical step we will identify potentially important 'predictors', which could be individual up- or down-regulated genes, gene clusters, regulatory pathways etc. These will be collated and iteratively used to build up our predictive model. We will concentrate on the most significant pathways for more in depth analysis by developing mathematical descriptions for pathways and then predict the effects of perturbations in the study population. Detailed cytometric analyses (CyTOF and Flow) and functional B-cell and T-cell assays will be performed, and will inform mechanistic animal model studies. During this study we will develop novel analytical tools and train scientists in systems immunology, build up large databases of childrens' immune responses, and define biomarkers that will predict frequent malaria episodes in children.</gtr:technicalSummary><gtr:potentialImpactText>This project seeks to use a systems approach to define the characteristics of protective immunity to the malaria parasite, Plasmodium falciparum, and to understand how the host response contributes to severe malaria in children. We believe our studies will be the first comprehensive dataset obtained from children in an endemic area of P. falciparum transmission that will link epidemiological and clinical data on malaria to a large range of immune parameters such as the gene expression of immune-related genes, cytokine and chemokine production, the breadth of B-cell/antibody responses and functional capacity of immune cells. 
Our data set will be of great value, and will be available to other Malaria immunologists, epidemiologists, and vaccine developers, who will be able to interrogate the data for their particular areas of immunological or other interest. The data set can also be used by any interested parties to define pathways, cells and molecules of interest that can be then investigated in mechanistic studies in experimental models. This would be an excellent way to bridge the gap between experimental models and human infection and disease by focussing on those responses that are directly relevant to human malaria. 
The plasma remaining from this study will be available to colleagues, who are already in the process of developing various P. falciparum proteomes for screening for vaccine candidate antigens and developing protein micro-arrays targeting blood-stage merozoite and variable surface antigens, respectively, and will be able to link the resultant data sets with the results of this study. 
We will collect samples such as P. falciparum DNA and RNA as well as human DNA in addition to the human RNA, peripheral blood cells and plasma to be used in our immunological studies. These samples will then be integrated into existing and planned large-scale studies funded by other sources such as Malariagen (www.malariagen.net), a network that integrates malaria epidemiology with genome studies on both the host and the malaria. This will enable us to expand our systems approach to bring together genetics with gene expression, functional immune responses and parasite variation. 
 This has huge potential for identifying markers for protective immunity and for identifying risk factors for severe disease. The data from this study will identify potential immune modulatory pathways that can be interrogated by interested immunologists from anywhere in the world. Furthermore the studies will provide important novel information on the relationships between genetic variability, gene expression and functional responses. Within the time scale of this project we will train young postgraduate and postdoctoral scientists in bioinformatics, predictive modeling and systems approaches to study human immunology and thereby establish a cohort of scientists who will further and expand this type of research in the UK and in Africa. 
Identification of patterns of immune responses that can be used as predictive markers of the child's ability or not to develop immunity will be of great value in informing rational vaccine design, monitoring vaccine efficacy and determining indicators for children at risk of severe disease. Our findings will aid in designing vaccines to target the most protective responses can be used by those organisations such as WHO, MVI, Gates Foundation, MRC, Wellcome Trust and pharmaceutical companies involved in furthering development of vaccines and therapeutic interventions. 
 Information that would accelerate malaria vaccine development against an infection to which half of the world's population are exposed would have a significant impact on the educational and economic development of those affected countries, and therefore in the longer term also on the global economy and British economy.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-05-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-05-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2303805</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heidelberg University Hospital</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Towards a highly effective multi-component vaccine against Plasmodium falciparum malaria</gtr:description><gtr:id>4C7F0DA4-5E8A-49EA-9BBC-7F073B32F36D</gtr:id><gtr:impact>Work ongoing</gtr:impact><gtr:outcomeId>58c7b4f15efa42.94726141-1</gtr:outcomeId><gtr:partnerContribution>Provided transgenic parasites to test potential vaccine candidates discovered in the &amp;quot;antigen discovery&amp;quot; part of the ongoing project.</gtr:partnerContribution><gtr:piContribution>Acquired new funding from the Alexander Humboldt Foundation to build on the existing work</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Multi-centre cohort study - new partners</gtr:description><gtr:id>9D47EB1A-815F-4C54-971F-95742A06539C</gtr:id><gtr:impact>Supported scientists from 2 african countries to attend the Federation of African Immunological Societies (FAIS) conference in Nairobi this year (2014)
Two scientists, one from Institut Pasteur Dakar, Senegal and one from Kintampo Health Research Centre visiting the KEMRI/Wellcome Trust Research Programme for research training visits for one and six months respectively in 2016</gtr:impact><gtr:outcomeId>54616408e42655.35561397-4</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and epidemiological expertise on malaria from the respective countries</gtr:partnerContribution><gtr:piContribution>Collaborations over shared samples and data to be generated to address research questions. Agreements to support capacity building of African researchers from these institutions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CyTOf analysis</gtr:description><gtr:id>E06F9ECC-BD2D-49CA-B8B2-BFF8174A04FF</gtr:id><gtr:impact>noe yet it only started this year</gtr:impact><gtr:outcomeId>5460e0a9172866.87584464-1</gtr:outcomeId><gtr:partnerContribution>DR Susanne Heck at Knigs will provide advice and train gin on the cytof</gtr:partnerContribution><gtr:piContribution>a member of the Langhporne lab will work on the Cytof</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bamako</gtr:collaboratingOrganisation><gtr:country>Mali, Republic of</gtr:country><gtr:department>Malaria Research and Training Centre (MRTC) Bamako</gtr:department><gtr:description>Multi-centre cohort study - new partners</gtr:description><gtr:id>20C3B9D9-E7BD-4657-9ED6-C93648C56023</gtr:id><gtr:impact>Supported scientists from 2 african countries to attend the Federation of African Immunological Societies (FAIS) conference in Nairobi this year (2014)
Two scientists, one from Institut Pasteur Dakar, Senegal and one from Kintampo Health Research Centre visiting the KEMRI/Wellcome Trust Research Programme for research training visits for one and six months respectively in 2016</gtr:impact><gtr:outcomeId>54616408e42655.35561397-3</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and epidemiological expertise on malaria from the respective countries</gtr:partnerContribution><gtr:piContribution>Collaborations over shared samples and data to be generated to address research questions. Agreements to support capacity building of African researchers from these institutions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kintampo Health Research Centre</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Multi-centre cohort study - new partners</gtr:description><gtr:id>A22F34CF-B754-4F4C-BA3A-4C6C80216B3B</gtr:id><gtr:impact>Supported scientists from 2 african countries to attend the Federation of African Immunological Societies (FAIS) conference in Nairobi this year (2014)
Two scientists, one from Institut Pasteur Dakar, Senegal and one from Kintampo Health Research Centre visiting the KEMRI/Wellcome Trust Research Programme for research training visits for one and six months respectively in 2016</gtr:impact><gtr:outcomeId>54616408e42655.35561397-1</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and epidemiological expertise on malaria from the respective countries</gtr:partnerContribution><gtr:piContribution>Collaborations over shared samples and data to be generated to address research questions. Agreements to support capacity building of African researchers from these institutions</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's and St Thomas' NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cytof analysis of human PBMC responding to malaria</gtr:description><gtr:id>DA471EAE-B085-43C2-8753-EA2DB75786A5</gtr:id><gtr:impact>a panel of tested reagents suitable to investigate PBMC responses in malaria</gtr:impact><gtr:outcomeId>5899b1abcc9b36.26103199-1</gtr:outcomeId><gtr:partnerContribution>advised on design and testing a panel of markers to delineate different populations of PBMC in P. falciparum- infected children. Training in the use of the Cytof and Cytobank.</gtr:partnerContribution><gtr:piContribution>multiparameter mass cytometry to investigate leukocyte responses to Plasmodium falciparum. design of study and optimisation of of cell preparation, completed testing of panel of reagents and analysed subpopulations of PBMC in malaria naive donors</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute Dakar</gtr:collaboratingOrganisation><gtr:country>Senegal, Republic of</gtr:country><gtr:description>Multi-centre cohort study - new partners</gtr:description><gtr:id>73F0F4DD-31BF-48F0-9EC4-EF0E0CE61ED1</gtr:id><gtr:impact>Supported scientists from 2 african countries to attend the Federation of African Immunological Societies (FAIS) conference in Nairobi this year (2014)
Two scientists, one from Institut Pasteur Dakar, Senegal and one from Kintampo Health Research Centre visiting the KEMRI/Wellcome Trust Research Programme for research training visits for one and six months respectively in 2016</gtr:impact><gtr:outcomeId>54616408e42655.35561397-2</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and epidemiological expertise on malaria from the respective countries</gtr:partnerContribution><gtr:piContribution>Collaborations over shared samples and data to be generated to address research questions. Agreements to support capacity building of African researchers from these institutions</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description> F, Osier attended Women in Science event, University of Warwick</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>24214EA4-BD42-4E75-9510-92A07C2AB49F</gtr:id><gtr:impact>We had a lively debate where we discussed the challenges and successes of women in science, engineering and mathematics. The audience were engaged and participated actively. they were mostly young women in social sciences and basic laboratory sciences who were all interested in developing research careers. It id too early to tell the impact of the meeting but the initial feedback from attendees was encouraging and the discussions showed that these were issues they were thinking about as they went about their studies</gtr:impact><gtr:outcomeId>58c7b73681a331.32732074</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://www2.warwick.ac.uk/research/priorities/internationaldevelopment/research/annualthemes/genderandinternationaldevelopment/womenandscience/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World malaria day at Mill Hill</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5FE7AE87-DEA0-49D1-BA26-DD80B476D94E</gtr:id><gtr:impact>we had an exhibition at the Mill Hill laboratory for world malaria day together with the other malaria groups. It was very well received within the institute and in 2017 it is planned to extend this to Midland rd site and for a Crick Late for the general public.</gtr:impact><gtr:outcomeId>5894b1c5f1b959.00085573</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>community sensitization (systems immunology study)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7BC7CE8F-D505-44E7-9904-6F31C9D28111</gtr:id><gtr:impact>They medical officers in charge of health provision for the study population that we will recruit from are now aware of the systems immunology for malaria susceptibility that is just about to start. This meeting opened up the process for community engagement and will be followed by several meetings of sensitizing the potential study participants of the new study.

The Kilifi County health provision team are happy to be involved in the new study, and happy to support our community engagement activities.</gtr:impact><gtr:outcomeId>5461cc3250c943.95729999</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Strategic Award</gtr:department><gtr:description>Strategic Award</gtr:description><gtr:end>2020-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>877196DC-8410-4DCC-B7E2-86A981C99488</gtr:id><gtr:outcomeId>56d998f13f9335.91533123</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Sofja Kovalevskaja Award</gtr:description><gtr:end>2021-10-02</gtr:end><gtr:fundingOrg>Alexander von Humboldt Foundation</gtr:fundingOrg><gtr:fundingRef>3.2 - 1184811 - KEN - SKP</gtr:fundingRef><gtr:id>C821330D-3D62-484B-9596-2B9FE4A00DC0</gtr:id><gtr:outcomeId>58c7b59f3326d4.36801566</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Generic pipeline to analyse antibody profiles based on protein microarray data and develop predictive models of clinical infections using random forests machine learning algorithm</gtr:description><gtr:id>EA1D4B38-72C0-4A06-AB04-78D714E48AC3</gtr:id><gtr:impact>Powerful technique to (i) identify important variables from high dimensional data sets, and (ii) develop predictive models of infection outcomes based on individual antibody profiles</gtr:impact><gtr:outcomeId>56d82607b87d70.11822444</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>analysis of protein microarray data</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Broad-based collaborations are becoming increasingly common among disease researchers. This is true for the SIMS project, where several partners are generating data ranging from clinical, RNA-Seq, proteomics and immunological data sets. To enable the researchers to organize and integrate these heterogeneous data early in the discovery process, standardize processes are needed to manage and integrate the data to gain new insights into pooled data and collaborate securely.
We are implementing the open source LabKey server (www.labkey.org), a web-based data integration platform, to meet the needs of the project to manage the multi-dimensional data being generated in the SIMS project. 

The SIMS LabKey instance is hosted and managed by KWTRP.</gtr:description><gtr:id>0CD4C1BB-5431-4B0D-9340-7ABCCE163D98</gtr:id><gtr:impact>Is providing a shared platform for all participants in the project to gain access to all the data being generated including SOPs and other relevant documents. Also server as a communication tool for the project collaborators.</gtr:impact><gtr:outcomeId>5694dd0f4e8952.07074870</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SIMS LabKey</gtr:title><gtr:type>Data handling &amp; control</gtr:type><gtr:url>http://labkey.kemri-wellcome.org:8080/labkey</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This reports provides an overview of the RNA-Seq data analysis pipeline from the first cross-sectional bleed (X1) using open-source software R</gtr:description><gtr:id>37A18A99-139E-44A8-8D4E-47815DB7A14E</gtr:id><gtr:impact>The report, and the the pipeline described therein, constitutes a major part of the general, data analytic methodology of this project. It is being described a general as possible to facilitate similar analysis on unrelated data sets in the future (both for this project and others).</gtr:impact><gtr:outcomeId>58c2aceb37b158.27651234</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RNA-Seq analysis of first cross-sectional bleed</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>R-based pipeline to perform differential gene expression analysis; currently based on microarray data but can be used as generic tool</gtr:description><gtr:id>CEC0F170-5668-44DE-9120-2A9DAD611AD3</gtr:id><gtr:impact>This pipeline should speed-up process of performing rudimentary gene expression analysis using opensource statistical software package R</gtr:impact><gtr:outcomeId>56d824a1f09fb5.71952117</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>differentail gene expression analysis in R</gtr:title><gtr:type>Computer model/algorithm</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Pipeline to perform rudimentary cluster analysis of gene expression data</gtr:description><gtr:id>6D30CCB8-AF28-46F2-944A-12BF53C7761B</gtr:id><gtr:impact>Speedup of performaing cluster analysis using generic R script</gtr:impact><gtr:outcomeId>56d8251767d8a3.77067913</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>cluster analysis of gene expression data in R</gtr:title><gtr:type>Computer model/algorithm</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>developed panels for antibodies for mass cytometry, including isotope labelling of selected Abs</gtr:description><gtr:id>43BD6A58-2844-4921-AE15-2B6531BEFC01</gtr:id><gtr:impact>this panel will enable a detailed investigation of PBMC responses to Plasmodium falciparum infected red blood cells of exposed children in Kilifi , Kenya using Mass Cytometry,</gtr:impact><gtr:outcomeId>56b8a47d02e554.58508673</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CytoF Panels</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>flow cytometry panel to detemine the major cellular components of human peripheral blood for later deconvoultion studies</gtr:description><gtr:id>2320B4D6-B20B-4644-821B-7CD0E8F383A0</gtr:id><gtr:impact>this enables us to detemine cell specific signatures from whole blood RNA seq data</gtr:impact><gtr:outcomeId>56aa392beb9aa5.44925235</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>FLow cytometry deconvolution panel for human whole blood</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>wehave developed a flow cytometry panels to deterine the cellaur components of peripheral blood, whic can be used to detemine cell specific signatures from RNA sequencing.</gtr:description><gtr:id>A269DE04-6652-46AF-894A-9F285B5B3F06</gtr:id><gtr:impact>we will now be able to deconvolute our RNA seq data and assign cell specific signatures.</gtr:impact><gtr:outcomeId>56aa374891c062.50872279</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>FLow cytometry deconvoution panel for whole blood</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>bar coding allows multiplexing samples for Cytof analysis</gtr:description><gtr:id>F6E74177-40B6-4B9F-B2BF-C2B0D093294F</gtr:id><gtr:impact>this allows us to save money of reagents and analysis time as multiple samples can be analysed in a single tube</gtr:impact><gtr:outcomeId>589491046550a8.86646831</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>bar  coding of PBMC samples for Cytof</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocol developed and optimised for extraction from 1ml of blood in Tempus tubes. (Manufacturers protocol requires 3 ml)</gtr:description><gtr:id>0401311F-E12C-4983-BFA6-F7D85EE5984F</gtr:id><gtr:impact>This is a critical step in enabling transcriptome analysis from blood samples of infants</gtr:impact><gtr:outcomeId>56d9772fc6ee18.78609455</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RNA extraction from 1ml Blood</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>deveoplement of panels of antibodies for Mass cytometry, including isotyope labelling of certin purtified antibodies</gtr:description><gtr:id>ABF64614-70DB-4AED-A999-8BFABFA0C853</gtr:id><gtr:impact>This panel will enable a very detailed analysis of PBMC responses to Plasmodium falciparum-infected red blood cells from exposed children in Kilifi, Kenya. The panel will be used to determine the phenotype of responding cells from selected children in the next longitudinal blled</gtr:impact><gtr:outcomeId>56b8a21b4f43c7.09723853</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CyTOF panels</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8B02F9C2-9355-4891-B123-367D77C4C564</gtr:id><gtr:title>Identification of immune signatures predictive of clinical protection from malaria.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c2d3485ce400dc4e9020527907d4eb"><gtr:id>40c2d3485ce400dc4e9020527907d4eb</gtr:id><gtr:otherNames>Valletta JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>5a2fd7b49bc786.94592902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73405146-4EB1-4C1D-A88C-14A75ED83352</gtr:id><gtr:title>Changes in Malaria Epidemiology in Africa and New Challenges for Elimination.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c828f1205f83499008c68e7405c7574"><gtr:id>2c828f1205f83499008c68e7405c7574</gtr:id><gtr:otherNames>Nkumama IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>58c7b269895820.11926242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1348B1C8-98D2-4A78-9D39-027ADB8C2890</gtr:id><gtr:title>Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57a4abdda25b92c3b33dd7b84605f0a7"><gtr:id>57a4abdda25b92c3b33dd7b84605f0a7</gtr:id><gtr:otherNames>Mogeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5aa0ca45e36fc0.97657855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DCD0B24-09EA-43B8-8B88-FB1A93E92295</gtr:id><gtr:title>Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria.</gtr:title><gtr:parentPublicationTitle>International journal for parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/094dc250b162ab5f7ad66b1440ea75f9"><gtr:id>094dc250b162ab5f7ad66b1440ea75f9</gtr:id><gtr:otherNames>Boyle MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0020-7519</gtr:issn><gtr:outcomeId>58c7b2d1c4e0b4.62774656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3384B5D-0DA7-4F75-A9E4-6A294842926E</gtr:id><gtr:title>The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological &amp;quot;natural experiment&amp;quot;.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b5f775dbe1ff55e47dbc33618065021"><gtr:id>7b5f775dbe1ff55e47dbc33618065021</gtr:id><gtr:otherNames>Bediako Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>58468b3d6cd071.05618735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE25593-BF91-4214-9466-A5FC063E8C0B</gtr:id><gtr:title>Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9b36f58c5a1712335213202743d2d88"><gtr:id>a9b36f58c5a1712335213202743d2d88</gtr:id><gtr:otherNames>Ndungu FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>56d99614563b96.71218303</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M003906/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>